BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27556188)

  • 1. CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma.
    Su J; Gao T; Jiang M; Wu L; Zeng W; Zhao S; Peng C; Chen X
    Oncotarget; 2016 Oct; 7(40):64778-64784. PubMed ID: 27556188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression.
    Zhao S; Wu L; Kuang Y; Su J; Luo Z; Wang Y; Li J; Zhang J; Chen W; Li F; He Y; Tao J; Zhou J; Xu X; Peng C; Chen X
    Int J Oncol; 2018 Dec; 53(6):2397-2408. PubMed ID: 30272281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.
    Su J; Chen X; Kanekura T
    Cancer Lett; 2009 Jan; 273(1):140-7. PubMed ID: 18778892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD147 interacts with NDUFS6 in regulating mitochondrial complex I activity and the mitochondrial apoptotic pathway in human malignant melanoma cells.
    Luo Z; Zeng W; Tang W; Long T; Zhang J; Xie X; Kuang Y; Chen M; Su J; Chen X
    Curr Mol Med; 2014; 14(10):1252-64. PubMed ID: 25470292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repressing CD147 is a novel therapeutic strategy for malignant melanoma.
    Hu X; Su J; Zhou Y; Xie X; Peng C; Yuan Z; Chen X
    Oncotarget; 2017 Apr; 8(15):25806-25813. PubMed ID: 28445958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD147-targeting siRNA inhibits cell-matrix adhesion of human malignant melanoma cells by phosphorylating focal adhesion kinase.
    Nishibaba R; Higashi Y; Su J; Furukawa T; Kawai K; Kanekura T
    J Dermatol; 2012 Jan; 39(1):63-7. PubMed ID: 21967109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of siRNA-mediated down-regulation of CD147 on human breast cancer cells].
    Li Z; Li D; Li J; Huang P; Qin H
    Zhonghua Bing Li Xue Za Zhi; 2015 Oct; 44(10):734-8. PubMed ID: 26702532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma.
    Chen X; Lin J; Kanekura T; Su J; Lin W; Xie H; Wu Y; Li J; Chen M; Chang J
    Cancer Res; 2006 Dec; 66(23):11323-30. PubMed ID: 17145878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD147 promotes melanoma progression through hypoxia-induced MMP2 activation.
    Zeng W; Su J; Wu L; Yang D; Long T; Li D; Kuang Y; Li J; Qi M; Zhang J; Chen X
    Curr Mol Med; 2014 Jan; 14(1):163-73. PubMed ID: 24090196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD147 regulates melanoma metastasis via the NFAT1-MMP-9 pathway.
    Liu N; Qi M; Li K; Zeng W; Li J; Yin M; Liu H; Chen X; Zhang J; Peng C
    Pigment Cell Melanoma Res; 2020 Sep; 33(5):731-743. PubMed ID: 32339381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.
    Huang P; Mao LF; Zhang ZP; Lv WW; Feng XP; Liao HJ; Dong C; Kaluba B; Tang XF; Chang S
    Thyroid; 2018 May; 28(5):613-623. PubMed ID: 29634399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway.
    Huang Q; Li J; Xing J; Li W; Li H; Ke X; Zhang J; Ren T; Shang Y; Yang H; Jiang J; Chen Z
    J Hepatol; 2014 Oct; 61(4):859-66. PubMed ID: 24801417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel interaction between calcium-modulating cyclophilin ligand and Basigin regulates calcium signaling and matrix metalloproteinase activities in human melanoma cells.
    Long T; Su J; Tang W; Luo Z; Liu S; Liu Z; Zhou H; Qi M; Zeng W; Zhang J; Chen X
    Cancer Lett; 2013 Oct; 339(1):93-101. PubMed ID: 23879967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphorylation of CD147 by Fyn plays a critical role for melanoma cells growth and metastasis.
    Zhang X; Huang Z; Guo Y; Xiao T; Tang L; Zhao S; Wu L; Su J; Zeng W; Huang H; Li Z; Tao J; Zhou J; Chen X; Peng C
    Oncogene; 2020 May; 39(21):4183-4197. PubMed ID: 32291412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathways.
    Liang G; Liu M; Wang Q; Shen Y; Mei H; Li D; Liu W
    Oncotarget; 2017 Apr; 8(17):28510-28525. PubMed ID: 28212537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma.
    Huang XQ; Chen X; Xie XX; Zhou Q; Li K; Li S; Shen LF; Su J
    Int J Clin Exp Pathol; 2014; 7(4):1651-66. PubMed ID: 24817962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD147/Basigin Is Involved in the Development of Malignant Tumors and T-Cell-Mediated Immunological Disorders via Regulation of Glycolysis.
    Kanekura T
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol-induced apoptosis is associated with regulating the miR-492/CD147 pathway in malignant melanoma cells.
    Zhao S; Tang L; Chen W; Su J; Li F; Chen X; Wu L
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):797-807. PubMed ID: 33009925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD147-induced cell proliferation is associated with Smad4 signal inhibition.
    Qin H; Rasul A; Li X; Masood M; Yang G; Wang N; Wei W; He X; Watanabe N; Li J; Li X
    Exp Cell Res; 2017 Sep; 358(2):279-289. PubMed ID: 28684116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming.
    Kendrick AA; Schafer J; Dzieciatkowska M; Nemkov T; D'Alessandro A; Neelakantan D; Ford HL; Pearson CG; Weekes CD; Hansen KC; Eisenmesser EZ
    Oncotarget; 2017 Jan; 8(4):6742-6762. PubMed ID: 28039486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.